349 related articles for article (PubMed ID: 33976943)
1. Emerging Roles of Impaired Autophagy in Fatty Liver Disease and Hepatocellular Carcinoma.
Niture S; Lin M; Rios-Colon L; Qi Q; Moore JT; Kumar D
Int J Hepatol; 2021; 2021():6675762. PubMed ID: 33976943
[TBL] [Abstract][Full Text] [Related]
2. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
3. Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth.
Dashti Z; Yousefi Z; Kiani P; Taghizadeh M; Maleki MH; Borji M; Vakili O; Shafiee SM
Metabolism; 2024 May; 154():155811. PubMed ID: 38309690
[TBL] [Abstract][Full Text] [Related]
4. Blueberry polyphenols play a preventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes.
Zhuge Q; Zhang Y; Liu B; Wu M
Ann Palliat Med; 2020 May; 9(3):1045-1054. PubMed ID: 32389004
[TBL] [Abstract][Full Text] [Related]
5. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
6. Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy.
Huang C; Zhou Y; Cheng J; Guo X; Shou D; Quan Y; Chen H; Chen H; Zhou Y
Front Endocrinol (Lausanne); 2023; 14():1145392. PubMed ID: 37020586
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver disease.
Jin S; Li Y; Xia T; Liu Y; Zhang S; Hu H; Chang Q; Yan M
J Adv Res; 2024 Feb; ():. PubMed ID: 38295876
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD.
An L; Wirth U; Koch D; Schirren M; Drefs M; Koliogiannis D; Niess H; Andrassy J; Guba M; Bazhin AV; Werner J; Kühn F
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677026
[TBL] [Abstract][Full Text] [Related]
9. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Johnston MP; Patel J; Byrne CD
Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
[TBL] [Abstract][Full Text] [Related]
10. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.
Sookoian S; Pirola CJ
PLoS One; 2013; 8(3):e58895. PubMed ID: 23516571
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity.
Xin SL; Yu YY
Dig Liver Dis; 2022 Aug; 54(8):1021-1029. PubMed ID: 35288065
[TBL] [Abstract][Full Text] [Related]
12. Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery.
Pi H; Liu M; Xi Y; Chen M; Tian L; Xie J; Chen M; Wang Z; Yang M; Yu Z; Zhou Z; Gao F
FASEB J; 2019 Nov; 33(11):11870-11883. PubMed ID: 31366243
[TBL] [Abstract][Full Text] [Related]
13. Function of Autophagy in Nonalcoholic Fatty Liver Disease.
Czaja MJ
Dig Dis Sci; 2016 May; 61(5):1304-13. PubMed ID: 26725058
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease.
Fan Y; Dong W; Wang Y; Zhu S; Chai R; Xu Z; Zhang X; Yan Y; Yang L; Bian Y
Front Immunol; 2022; 13():959495. PubMed ID: 35967372
[TBL] [Abstract][Full Text] [Related]
15. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
Liu C; Liao JZ; Li PY
World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
[TBL] [Abstract][Full Text] [Related]
16. Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease.
Khambu B; Yan S; Huda N; Liu G; Yin XM
Liver Res; 2018 Sep; 2(3):112-119. PubMed ID: 31123622
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and non-alcoholic fatty liver disease.
Lavallard VJ; Gual P
Biomed Res Int; 2014; 2014():120179. PubMed ID: 25295245
[TBL] [Abstract][Full Text] [Related]
18. Synergy between NAFLD and AFLD and potential biomarkers.
Lakshman R; Shah R; Reyes-Gordillo K; Varatharajalu R
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S29-34. PubMed ID: 26189985
[TBL] [Abstract][Full Text] [Related]
19. Autophagy and liver cancer.
Chao X; Qian H; Wang S; Fulte S; Ding WX
Clin Mol Hepatol; 2020 Oct; 26(4):606-617. PubMed ID: 33053934
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
